高级搜索

肺癌患者血清EGFR突变诊断实验的Meta分析

张学德, 李 维, 刘晓丽, 张玉萍, 侯彦丽, 牛泽群, 杨拴盈

张学德, 李 维, 刘晓丽, 张玉萍, 侯彦丽, 牛泽群, 杨拴盈. 肺癌患者血清EGFR突变诊断实验的Meta分析[J]. 肿瘤防治研究, 2014, 41(05): 409-412. DOI: 10.3971/j.issn.1000-8578.2014.05.014
引用本文: 张学德, 李 维, 刘晓丽, 张玉萍, 侯彦丽, 牛泽群, 杨拴盈. 肺癌患者血清EGFR突变诊断实验的Meta分析[J]. 肿瘤防治研究, 2014, 41(05): 409-412. DOI: 10.3971/j.issn.1000-8578.2014.05.014
ZHANG Xuede, LI Wei, LIU Xiaoli, ZHANG Yuping, HOU Yanli, NIU Zequn, YANG Shuanying. Diagnostic Value of Serum from Lung Cancer Patient in Detection of Epidermal Growth Factor Receptor Mutation:A Meta Analysis[J]. Cancer Research on Prevention and Treatment, 2014, 41(05): 409-412. DOI: 10.3971/j.issn.1000-8578.2014.05.014
Citation: ZHANG Xuede, LI Wei, LIU Xiaoli, ZHANG Yuping, HOU Yanli, NIU Zequn, YANG Shuanying. Diagnostic Value of Serum from Lung Cancer Patient in Detection of Epidermal Growth Factor Receptor Mutation:A Meta Analysis[J]. Cancer Research on Prevention and Treatment, 2014, 41(05): 409-412. DOI: 10.3971/j.issn.1000-8578.2014.05.014

肺癌患者血清EGFR突变诊断实验的Meta分析

基金项目: 国家自然科学基金资助项目(81172234)
详细信息
    作者简介:

    张学德(1978-),男,博士,主治医师,主要从事肺癌基础与临床研究

    通讯作者:

    杨拴盈,E-mail:yangshuanying66@163.com

  • 中图分类号: R734.2

Diagnostic Value of Serum from Lung Cancer Patient in Detection of Epidermal Growth Factor Receptor Mutation:A Meta Analysis

  • 摘要: 目的 评价肺癌患者血清EGFR突变诊断试验的准确性。方法 收集关于肺癌患者血清与肺癌组织表皮生长因子受体(EGFR)突变检测相关研究的文献,并进行Meta分析,绘制SROC曲线。结果 共纳入9篇文献,包括555例研究对象,合并敏感度为0.65,合并特异性为0.92,合并阳性似然比为8.29,合并阴性似然比为0.37,SROC曲线下面积0.94。结论 肺癌患者血清与肿瘤组织的EGFR 突变具有较高的一致性,利用外周血进行EGFR突变检测是一种可行办法。

     

    Abstract: Objective To evaluate the diagnostic accuracy of serum from lung cancer patients in detection of epidermal growth factor receptor mutation. Methods Literatures on detecting epidermal growth factor receptor (EGFR) mutation in serum and tissue from patients with lung cancer were collected for meta-analysis and SROC curve. Results Nine literatures including 555 cases were involved. Meta-analyses showed that sensitivity, specifi city, positive likelihood ratio, negative likelihood ratio of detecting EGFR mutation in serum compared with tissue were 0.65, 0.92, 7.85 and 0.37 respectively and the area under the SROC curve (AUC) was 0.94. Conclusion The detection of EGFR mutation is highly consistent in tissues and plasma DNA samples from lung cancer patients. The detection in plasma may serve as a feasible screening method for detecting EGFR mutations.

     

  • [1] Jemal A,Siegel R,Ward E,et al. Cancer statistics,2009[J]. CA Cancer J Clin,2009,59(4):225-49.
    [2] Lynch TJ, Bell DW, Sordella R, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib[J]. N Engl J Med,2004, 35 0(21):2129-39.
    [3] National Comprehensive Cancer Network. NCCN guidelines: non-small cell lung cancer Version 3 [EB/OL]. 2011-08-30.http:// www.nccn.com.
    [4] Whiting P, Rutjes AW, Reitsma JB, et al. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews[J]. Zhongguo Xun Zheng Yi Xue Za Zhi, 2007,7(4):296-306. [Whiting P, Rutjes AW, Reitsma JB,等.QUADAS的制定:用于系统评价中评价诊断 性研究质量的工具[J].中国循证医学杂志,2007,7(4):296-306.]
    [5] Zhang TS, Zhong WZ. Meta-DiSc software in Meta-Analysis of diagnostic test[J]. Xun Zhen Yi Xue, 2008,8(2):97-100,108.[张天 嵩,钟文昭. Meta-Disc软件在诊断试验Meta分析中的应用[J].循 证医学,2008,8(2):97-100,108.]
    [6] Liu GJ, Wu TX. Summary ROC curve-diagnostic test method of Meta-analysis[J]. Zhongguo Xun Zheng Yi Xue Za Zhi,2003,3(1): 41 -4.[刘关键,吴泰相.诊断性试验的Meta分析--SROC曲线法介 绍[J] 中国循证医学杂志, 2003,3(1): 41-4. ]
    [7] Kimura H, Kasahara K, Kawaishi M, et al. Detection of epidermal growth factor receptor mutations in serum as a predictor of the response to gefi tinib in patients with non-small-cell lung cancer [J]. Clin Cancer Res,2006,12(13): 3915-21.
    [8] Kimura H, Suminoe M, Kasahara K, et al. Evaluation of epidermal growth factor receptor mutation status in serum DNA as a predictor of response to gefitinib (IRESSA)[J]. Br J Cancer, 20 07,97(6):778-84.
    [9] Bai H,Zhao J,Wang SH,et al. The detection by denaturing high performance liquid chromatography of epidermal growth factor receptor mutation in tissue and peripheral blood from patients with advanced non-small cell lung cancer[J]. Zhonghua Jie He He Hu Xi Za Zhi,2008,31(12):891-6.[白桦,赵军,王书航,等.变性高效液 相色谱法检测非小细胞肺癌患者外周血及肿瘤组织表皮生长 因子受体突变[J].中华结核和呼吸杂志,2008,31(12):891-6.]
    [10] He C, Liu M, Zhou C, et al. Detection of epidermal growth factor receptor mutations in plasma by mutant-enriched PCR assay for prediction of the response to gefi tinib in patients with non-smallcell lung cancer[J]. Int J Cancer,2009,125(10): 2393-9.
    [11] Yung TK, Chan KC, Mok TS, et al. Single-molecule detection of epidermal growth factor receptor mutations in plasma by microfl uidics digital PCR in non-small cell lung cancer patients[J]. Clin Cancer Res,2009,15(6): 2076-84.
    [12] Brevet M, Johnson ML, Azzoli CG, et al. Detection of EGFR mutations in plasma DNA from lung cancer patients by mass spectrometry genotyping is predictive of tumor EGFR status and response to EGFR inhibitors[J]. Lung Cancer, 2011,73(1): 96-102.
    [13] Zhou N,Li LY,Zheng Z,et al. Detection of epidermal growth factor receptor gene mutations in tumor and matched serum in lung cancer patients by Scorpions amplification refractory mutation system[J]. Ai Zheng Jin Zhan,2011,9(1):19-26.[周南, 李龙芸,郑直,等.蝎形探针扩增阻滞突变系统检测肺癌患者 血清与肿瘤组织中表皮生长因子受体基因突变[J]. 癌症进 展,2011,9(1):19-26.]
    [14] Zhao Y,DouYL,Guo HQ,et al. Detect serum circulating EGFR mutation with qPCR-HRM method[J]. Ai Zheng Jin Zhan,2012,10(1):10-2. [赵宇, 窦亚玲,郭惠琴,等.qPCR-HRM法检 测NSCLC血清循环EGFR突变[J].癌症进展,2012,10(1):10-2 .]
    [15] Zhao X, Han RB, Zhao J, et al. Comparison of epidermal growth factor receptor mutation statuses in tissue and plasma in stage IIV non-small cell lung cancer patients[J]. Respiration,2013,85(2): 11 9-25.
    [16] Fan X, Furnari FB, Cavenee WK, et al. Non-isotopic silver-stained SSCP is more sensitive than automated direct sequencing for the detection of PTEN mutations in a mixture of DNA extracted from normal and tumor cells[J]. Int J Oncol,2001,18(5):1023-6.
    [17] Asano H, Toyooka S, Tokumo M, et al. Detection of EGFR gene mutation in lung cancer by mutant-enriched polymerase chain reaction assay[J]. Clin Cancer Res,2006,12(1): 43-8.
    [18] Zhao Y. Advanced of detecting nucleic acids in Peripheral blood from patients with lung cancer as a new method[J]. Ai Zheng Jin Zhan,2011,9(4):404-7. [赵宇.循环中的核酸作为肺癌检查新手 段的研究进展[J].癌症进展,2011,9(4):404-7.]
    [19] Rosell R, Moran T, Queralt C, et a1. Screening for epidermal growth factor receptor mutations in lung cancer[J]. N Engl J Med,2009,361(10):958-67.
计量
  • 文章访问数:  1326
  • HTML全文浏览量:  315
  • PDF下载量:  828
  • 被引次数: 0
出版历程
  • 收稿日期:  2013-03-28
  • 修回日期:  2013-06-10
  • 刊出日期:  2014-05-24

目录

    /

    返回文章
    返回
    x 关闭 永久关闭